M. Sekimizu

发表

A Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in Children.

A. Kada, A. Saito, Tetsuya Mori, 2020, Acta medica Okayama.

Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

K. Horibe, A. Kada, A. Saito, 2020, Klinische Pädiatrie.

Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol

K. Horibe, A. Kada, A. Saito, 2018, BMC Cancer.

Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

Y. Kogure, Y. Inoue, A. Saito, 2019, BMJ Open Respiratory Research.

A Case of NUT Midline Carcinoma With Complete Response to Gemcitabine Following Cisplatin and Docetaxel

K. Horibe, N. Maeda, S. Moritani, 2014, Journal of pediatric hematology/oncology.

Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled trial

H. Nagai, A. Kada, R. Asada, 2017, Nagoya journal of medical science.

Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib

K. Horibe, Hiroyoshi Hattori, N. Maeda, 2014, Leukemia & lymphoma.

Pediatric follicular lymphoma in Japan

Takeshi Mori, Yuhki Koga, A. Nakazawa, 2017, International Journal of Hematology.

Association between sites and severity of eczema and the onset of cow’s milk and egg allergy in children

K. Horibe, Hiroyoshi Hattori, N. Maeda, 2020, PloS one.

Efficacy and safety of administering pediatric treatment to adolescent patients with mature B‐cell non‐Hodgkin lymphoma within the Japanese Pediatric Leukemia/Lymphoma Study Group clinical trial

K. Horibe, M. Tsurusawa, R. Kobayashi, 2018, Pediatric blood & cancer.

Treatment of pediatric lymphoma in Japan: Current status and plans for the future

Takeshi Mori, Yuhki Koga, A. Nakazawa, 2015, Pediatrics international : official journal of the Japan Pediatric Society.

Low NUDT15 expression levels due to biallelic NUDT15 variants and 6‐mercaptopurine intolerance

Scott A. Brown, Motohiro Kato, N. Kiyokawa, 2022, British journal of haematology.

Phase II Clinical Trial for Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma (Japanese Leukemia/Lymphoma Study Group Trial LLB-NHL03) : Study Protocol for Nationwide Multicenter Trial.

K. Horibe, J. Fujimoto, T. Takimoto, 2018, Acta medica Okayama.

A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)

K. Horibe, A. Saito, Y. Kosaka, 2022, International Journal of Hematology.

Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia/lymphoma study group B-NHL03 study

K. Horibe, A. Saito, M. Gosho, 2016, Leukemia & lymphoma.

Characteristics of genetic alterations of peripheral T‐cell lymphoma in childhood including identification of novel fusion genes: the Japan Children’s Cancer Group (JCCG)

K. Okamura, Y. Hayashi, Hiroko Ogata-Kawata, 2021, British journal of haematology.

Chromosome abnormalities in advanced stage T‐cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature

Y. Hayashi, K. Horibe, A. Saito, 2011, British journal of haematology.

Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial

U. Tateishi, K. Horibe, I. Choi, 2020, Cancer science.

Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

K. Ohshima, K. Horibe, N. Kiyokawa, 2017, Journal of pediatric hematology/oncology.

Osteosarcoma After Bone Marrow Transplantation

K. Horibe, N. Maeda, Y. Nishida, 2013, Journal of pediatric hematology/oncology.

Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

K. Ohshima, K. Horibe, J. Fujimoto, 2015, Pediatric blood & cancer.

The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin‐Frankfurt‐Münster (BFM)95‐based protocol

K. Horibe, T. Imamura, H. Hiramatsu, 2021, British journal of haematology.

Non‐germinal center B‐cell subtype of pediatric diffuse large B‐cell lymphoma in Japan: A retrospective cohort study

W. Klapper, H. Iwafuchi, A. Nakazawa, 2023, Pediatric blood & cancer.

A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)

K. Horibe, A. Saito, Y. Kosaka, 2022, International Journal of Hematology.

Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia

M. Sanada, H. Hiramatsu, H. Toyoda, 2023, International Journal of Hematology.

Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB‐NHL03 Study

K. Ohshima, K. Horibe, J. Fujimoto, 2016, Pediatric blood & cancer.

Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study

T. Komori, M. Asakura, Y. Motoyoshi, 2021, Orphanet Journal of Rare Diseases.

The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study.

S. Baba, Katsumasa Nakamura, A. Kada, 2018, Acta medica Okayama.

Study Protocol for a Multicenter, Open-Label, Single-Arm Study of Tranilast for Cardiomyopathy of Muscular Dystrophy.

M. Asakura, A. Saito, T. Matsumura, 2019, The Kurume medical journal.

Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature

C. Imai, H. Goto, Haruko Iwabuchi, 2016, International Journal of Hematology.

Prognostic value of minimal disseminated disease assessed using digital polymerase chain reaction for 3' ALK assays in pediatric anaplastic lymphoma kinasepositive anaplastic large cell lymphoma

K. Horibe, H. Iwafuchi, T. Takimoto, 2023, Haematologica.